The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| HERON THERAPEUTICS INC | COM | 427746102 | 150,826 | 8,332,907 | SH | SOLE | 8,332,907 | 0 | 0 | ||
| HERON THERAPEUTICS INC | COM | 427746102 | 2,416 | 133,470 | SH | OTR | 1 | 0 | 133,470 | 0 | |
| IGNYTA INC | COM | 451731103 | 62,165 | 2,328,279 | SH | SOLE | 2,328,279 | 0 | 0 | ||
| LA JOLLA PHARMACEUTICAL CO | COM | 503459604 | 110,713 | 3,440,419 | SH | SOLE | 3,440,419 | 0 | 0 | ||
| ODONATE THERAPEUTICS INC | COM | 676079106 | 305,058 | 12,202,338 | SH | SOLE | 12,202,338 | 0 | 0 | ||